Back
Capricor Therapeutics, Inc. Stock Predictions
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
61
CAPR
Capricor Therapeutics, Inc.
Last Price:
$25.42
Seasonality Move:
25.31%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiCapricor Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Capricor Therapeutics, Inc. has on average historically risen by 25.6% based on the past 20 years of stock performance.
-
Capricor Therapeutics, Inc. has risen higher in 9 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 45%
-
Is Capricor Therapeutics, Inc. Stock Undervalued?The current Capricor Therapeutics, Inc. [CAPR] share price is $29.96. The Score for CAPR is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
CAPR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Capricor Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Capricor Therapeutics, Inc. has on average historically risen by 25.6% based on the past 20 years of stock performance.
Capricor Therapeutics, Inc. Stock Rating
Buy
61
Capricor Therapeutics, Inc. (CAPR)
is a Buy
Is Capricor Therapeutics, Inc. overpriced?
-
Capricor Therapeutics, Inc. has risen higher in 9 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 45%
Capricor Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
capricor.com
52-Week Data
52-Week High:
40.37
52-Week Low:
4.30
Prediction Charts
Market Cap:
1.4B
Price in USD:
29.96
Volume:
57M
Beta:
2.07
Technical Analysis
SMA50:
6.85
SMA100:
6.91
SMA200:
9.12
52-Wk Change:
81.47%
Stock Predictions
-
Is Capricor Therapeutics, Inc. stock public?Yes, Capricor Therapeutics, Inc. is a publicly traded company.
-
What is the Capricor Therapeutics, Inc. stock quote today?The Capricor Therapeutics, Inc. stock price is 29.96 USD today.
-
How to buy Capricor Therapeutics, Inc. stock online?You can buy Capricor Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-13 | 5.83 | 5.77 | 6.04 | 5.71 |
| Nov-14 | 5.60 | 5.60 | 5.82 | 5.52 |
| Nov-17 | 5.60 | 5.69 | 5.99 | 5.53 |
| Nov-18 | 5.56 | 5.64 | 5.77 | 5.54 |
| Nov-19 | 5.68 | 5.77 | 5.89 | 5.60 |
| Nov-20 | 5.82 | 5.69 | 6.01 | 5.67 |
| Nov-21 | 5.63 | 5.75 | 6.00 | 5.51 |
| Nov-24 | 5.55 | 4.64 | 5.61 | 4.40 |
| Nov-25 | 4.45 | 4.60 | 4.84 | 4.30 |
| Nov-26 | 4.66 | 5.19 | 5.20 | 4.63 |
| Nov-28 | 5.26 | 5.35 | 5.92 | 5.22 |
| Dec-1 | 5.35 | 6.65 | 7.23 | 5.35 |
| Dec-2 | 6.75 | 6.36 | 6.82 | 6.15 |
| Dec-3 | 30.00 | 29.96 | 40.37 | 21.50 |
Capricor Therapeutics, Inc. Earnings
Capricor Therapeutics, Inc. Earnings Report: Per Share Capricor Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Capricor Therapeutics, Inc. Forecast Revenue Growth
Capricor Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Capricor Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $1.68 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.07 per share, and an increase next year of $2.50 per share.
* Capricor Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.